CLDN18 and neoplasm: Accordingly, the expression of the target antigen CLDN18 was abolished only in tumors of this group, indicating that H9 CAR-IL15 T cells rapidly and efficiently engaged and killed antigen-positive tumor cells (Figures 4E, G).